Since april 1957 to april 1986, the Gynecologic Oncologic Unit of San Juan de Dios Hospital, Santiago, registered 255 cases of endometrial carcinoma. 48 cases where clinically etapified because of no previous pelviabdominal surgical exploration in: Stage I: 27 cases (56.3%); II: 6 (12.5%); III: 7 (14.6%); IV: 1 (2.1%). The remainder 207 cases were surgically etapified: I: 155 cases (74.9%); II: 10 (4.83%); III: 31 (14.92%) and IV: 11 cases (5.32%). Fourteen patients of the first group and 2 of the second one received palliative therapy. Primary therapy was performed with curative intention in 237 cases (34 clinically etapified and 203 surgically etapified). Stage I: 181 cases (76.37%), (26 clinical, 155 surgical); Stage II: 16 (4.92%). (6.10); Stage III: 31 (14.33%), (2.29) and Stage IV: 9 cases (4.4%), (0 + 9). Four different kinds of therapies were performed: A: only surgery in 153 cases (65%); B: surgery plus radiation in 49 (21%); C: radiation plus surgery in 20 cases (8.44%) and D: only radiation in: 15 cases (6.33%). Five years survival with no evidence of disease (SNFD) in 116 cases (70.04% of the 237 patients), and 58 cases (24.47%) died by endometrial cancer; 11 (4.64%) by intercurrent disease and 2 (0.84%) were lost from follow up. Survivor's distribution was: Stage I: 140 (77.34%); II: 12 (75%); III: 14 (45.16%). Five years survival according to therapy: A: 114 (74.51%); B: 36 (73.5%; C: 15 (75%); D: 1 (8.66%). In Stage I distribution of survivor was: A: 83.1%; B: 74.2%; C: 81.25%; and D: 10%.(ABSTRACT TRUNCATED AT 250 WORDS)